Molecular imaging of gliomas with PET: opportunities and limitations. - sprookjes - yvandenbroek - TriplyDB

Molecular imaging of gliomas with PET: opportunities and limitations.

Molecular imaging of gliomas with PET: opportunities and limitations.

http://www.wikidata.org/entity/Q33961188

about

Emerging methods for disease monitoring in malignant gliomas Getting into the brain: liposome-based strategies for effective drug delivery across the blood-brain barrier DW-MRI as a biomarker to compare therapeutic outcomes in radiotherapy regimens incorporating temozolomide or gemcitabine in glioblastoma Dynamic PET and Optical Imaging and Compartment Modeling using a Dual-labeled Cyclic RGD Peptide Probe.Evaluation of dynamic contrast-enhanced T1-weighted perfusion MRI in the differentiation of tumor recurrence from radiation necrosis.Treatment-related brain tumor imaging changes: So-called "pseudoprogression" vs. tumor progression: Review and future research opportunities Diagnostic discrepancies in malignant astrocytoma due to limited small pathological tumor sample can be overcome by IDH1 testing Comparison of magnetic resonance spectroscopy and positron emission tomography in detection of tumor recurrence in posttreatment of glioma: A diagnostic meta-analysis.Imaging mimics of primary malignant tumors of the central nervous system (CNS).Current status and future role of brain PET/MRI in clinical and research settings.Hybrid MR-PET in Neuroimaging.[Molecular imaging in neurological diseases].Facile synthesis of SSR180575 and discovery of 7-chloro-N,N,5-trimethyl-4-oxo-3(6-[(18)F]fluoropyridin-2-yl)-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-acetamide, a potent pyridazinoindole ligand for PET imaging of TSPO in cancer.(68)Ga-PRGD2 PET/CT in the evaluation of Glioma: a prospective study.Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivo Prospective Study of (68)Ga-NOTA-NFB: Radiation Dosimetry in Healthy Volunteers and First Application in Glioma Patients.Anticalins directed against the fibronectin extra domain B as diagnostic tracers for glioblastomas.Preclinical TSPO Ligand PET to Visualize Human Glioma Xenotransplants: A Preliminary Study (18)F-FDG PET-CT: a powerful tool for the diagnosis and treatment of relapsing polychondritis.Usefulness of FDG, MET and FLT-PET studies for the management of human gliomas.Potential role for magnetoencephalography in distinguishing low- and high-grade gliomas: a preliminary study with histopathological confirmation.Multi-modal imaging of tumor cellularity and Tryptophan metabolism in human Gliomas.Pilot Preclinical and Clinical Evaluation of (4S)-4-(3-[18F]Fluoropropyl)-L-Glutamate (18F-FSPG) for PET/CT Imaging of Intracranial Malignancies.Amino-acid PET versus MRI guided re-irradiation in patients with recurrent glioblastoma multiforme (GLIAA) - protocol of a randomized phase II trial (NOA 10/ARO 2013-1).Diagnostic and prognostic value of 18F-DOPA PET and 1H-MR spectroscopy in pediatric supratentorial infiltrative gliomas: a comparative study.18F-fluorothymidine PET imaging in gliomas: an update.Tryptophan PET in pretreatment delineation of newly-diagnosed gliomas: MRI and histopathologic correlates Split-dose technique for FDG PET/CT-guided percutaneous ablation: a method to facilitate lesion targeting and to provide immediate assessment of treatment effectiveness.Monitoring of Tumor Growth with [(18)F]-FET PET in a Mouse Model of Glioblastoma: SUV Measurements and Volumetric Approaches.Perfusion and diffusion MRI combined with ¹¹C-methionine PET in the preoperative evaluation of suspected adult low-grade gliomas.Imaging tumor burden in the brain with 89Zr-transferrin Interrogating tumor metabolism and tumor microenvironments using molecular positron emission tomography imaging. Theranostic approaches to improve therapeutics.Clinical use of (11)C-methionine and (18)F-FDG-PET for germinoma in central nervous system.Clinical aggressiveness of malignant gliomas is linked to augmented metabolism of amino acids.Technical Issues of [(18)F]FET-PET Imaging for Radiation Therapy Planning in Malignant Glioma Patients - A Review.Performance of 18F-FET versus 18F-FDG-PET for the diagnosis and grading of brain tumors: systematic review and meta-analysis.The role of surgery in grade II/III oligodendroglial tumors.Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas.Neurologic Applications of PET/MR Imaging.Molecular imaging and cancer gene therapy.

P2860

Q27023823-1A3793B1-14D2-4F15-A144-F8434D5D6445 Q28071873-4C1DD570-D4E3-4472-B1A4-790C9723CAC9 Q28730443-B3D15188-2A45-4088-865F-FD0CCEDF15EC Q30524330-AF7942AE-7DA6-44DF-BB6D-BD081B5C104D Q30582849-B51D87D7-0FB2-4792-9537-75AE559EEF1B Q30627773-5CB25188-3856-410D-9CCF-4AD9AEC80E07 Q30810936-2BAEE3F2-874D-4777-84C5-58819E43AF44 Q30811922-E98C5AF0-0486-49AE-ACE5-452BCCA54729 Q30831008-289C249F-A6FC-4982-A891-1892E245AD63 Q30883711-58B66BCF-6598-48DF-ACD9-6917DE3C7159 Q30984050-F1C751C4-E510-48F6-AE49-F1D24C771366 Q31108303-D84620A7-2357-4F25-AA39-466F044CDD4B Q34175347-957FE3DB-C190-4ED0-A056-A99C0B42FBB4 Q34473605-33016E7D-7AB3-4038-961D-92698745FB61 Q35606075-B366A504-C098-4D66-B431-818787695B5D Q35633357-470CE65D-315D-49F3-8ABE-CAAA04B18C53 Q35793074-342E408D-15E3-4E70-8F25-166FDA498A42 Q35827097-C78539E3-94FF-45FC-A6B1-5DE6A7B578CC Q35830495-9DB212BA-3F29-4C61-9EE8-40AB15FBCC9F Q35912078-0166C238-E5BF-426E-B861-04A96E600B11 Q35914520-1B0ACC8A-F13A-4F78-A62B-190BA0194228 Q35923158-F6A4B140-7A13-4427-9E1F-4726FBF862E4 Q35927273-F290233A-073E-43EE-9F11-0351F46EAAA2 Q36157048-4CFD0883-26A5-4194-9EF8-6F7D2A09CC6D Q36250739-7ACF9C8A-DC40-4176-B161-2402681F82B7 Q36404866-4B1D7787-45A4-426B-82FE-A0D6DDE9F8C9 Q36644371-ADD3EE6C-0A41-4E67-A924-6953C89F41F0 Q36946481-7BC04CC6-E897-455F-87A3-5FFAA4564285 Q37000245-59FE4583-F8B0-4E69-99C2-DF281912FB95 Q37092483-AB11A55B-9F92-48DD-9249-F2051329A1E0 Q37106244-CEC4A923-DB79-4D09-811C-2ABBD1A30224 Q37236103-DC202F21-8E05-422A-B9B4-61C699F7A7D5 Q37589387-C87CB53D-CAE2-48D3-A7E8-D12DCDFC5AD4 Q37730054-55B0631A-F4DC-45D8-9DE0-CB41D60FAE5D Q38051641-1C6AFB5D-BE8D-42A3-9369-6DCCFAA8F5F4 Q38561073-20BC8E23-F4F8-4AD0-8C4A-20E4DCC74680 Q38610485-BDD61756-BBC0-4358-BC55-D1665DEFACDB Q38815396-59F276A9-C885-4A7D-A6F8-09650A3D628B Q38846608-EA4AA5D3-45A0-417D-89AC-A47017910B12 Q39011437-72142D07-4033-49C1-B935-982ACA9C1071

P2860

Molecular imaging of gliomas with PET: opportunities and limitations.

http://www.wikidata.org/entity/Q33961188

description

2011 nî lūn-bûn

@nan

2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Molecular imaging of gliomas with PET: opportunities and limitations.

@ast

Molecular imaging of gliomas with PET: opportunities and limitations.

@en

type

label

Molecular imaging of gliomas with PET: opportunities and limitations.

@ast

Molecular imaging of gliomas with PET: opportunities and limitations.

@en

prefLabel

Molecular imaging of gliomas with PET: opportunities and limitations.

@ast

Molecular imaging of gliomas with PET: opportunities and limitations.

@en

P1433

Q33961188-BF558DCF-95C6-45F5-BFEC-982F942BB718

P1476

Q33961188-E0932967-9E0E-40BB-B500-11472A502196

P2093

Q33961188-01B8355A-8038-4563-95B0-834163557B59

Q33961188-2C13E74A-3FE4-407A-B4DD-AA7F2BD6CDAE

Q33961188-35855969-B6FA-4A48-B77F-4D9FC06FABF1

Q33961188-853496CC-89BD-44A1-AFB6-2742E6E1A4EA

P2860

Q33961188-084FBBD2-A73A-40B3-957B-2F733330F720

Q33961188-0969A1F1-2C21-4493-ABD5-8E52E279B2B2

Q33961188-0AC00017-8037-41D5-984D-542BAA36A63B

Q33961188-0D3F4667-27A4-4ABD-8210-1332EA7486C7

Q33961188-0F74578A-E75C-402B-BAD5-5AB97C39F89A

Q33961188-105058CA-0413-433D-BEE7-CBD0E5C9CFE9

Q33961188-10FCC095-FBAF-44A7-83B9-16B888A051C6

Q33961188-1354CCB8-DDB5-42CE-8EB5-B75C5CD40BEA

Q33961188-15323B15-8056-4952-8B8F-4500C78DE634

Q33961188-18BC250B-63CB-48FF-9C27-6A531B90A6E7

P304

Q33961188-0A86A72E-D01D-4431-AD6B-BB2CAA9EF4D7

P31

Q33961188-AC0C0DA6-C3EE-4A3D-B5FC-40BC4123371E

P356

Q33961188-2BBC4BD0-60AD-489A-A166-FC264C22ACD2

P433

Q33961188-23F4BA66-F41E-4A54-B2AB-353282D6E33A

P478

Q33961188-52217BBD-FBAB-464A-A424-703EFE643C23

P50

Q33961188-196D585A-9F47-43C1-AC58-816416C1A388

Q33961188-3AC3EA62-0E0D-4954-9305-BE940F109C95

Q33961188-9FB1EB70-D027-4E8A-8EED-72EA73367257

P577

Q33961188-526804F7-BB86-4C19-9705-AEBD2E23D7FE

P5875

Q33961188-8D0E5369-1913-4FDD-BB37-28F5C997D159

P698

Q33961188-B179E3F9-12F3-4699-8CF7-F63E5A2996D5

P932

Q33961188-0023AE1C-D8F7-4F02-A5D4-0AEF20F24574

P356

P1433

P1476

Molecular imaging of gliomas with PET: opportunities and limitations.

@en

P2093

Bogdana Suchorska

http://www.w3.org/2001/XMLSchema#string

Christian la Fougère

http://www.w3.org/2001/XMLSchema#string

Friedrich-Wilhelm Kreth

http://www.w3.org/2001/XMLSchema#string

Peter Bartenstein

http://www.w3.org/2001/XMLSchema#string

P2860

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Angiogenesis in cancer and other diseases

Comparisons of anti-human immunodeficiency virus activities, cellular transport, and plasma and intracellular pharmacokinetics of 3'-fluoro-3'-deoxythymidine and 3'-azido-3'-deoxythymidine

PET in differentiation of recurrent brain tumor from radiation injury.

Immediate post-radiotherapy changes in malignant glioma can mimic tumor progression.

Imaging in neurooncology

Positron emission tomography for radiation treatment planning.

Survival rates and patterns of care for patients diagnosed with supratentorial low-grade gliomas: data from the SEER program, 1973-2001.

Solitary brain lesions enhancing at MR imaging: evaluation with fluorine 18 fluorocholine PET.

Clinical applications of PET in brain tumors.

P304

806-819

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/NEUONC/NOR054

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

Jörg-Christian Tonn

Friedrich-Wilhelm Kreth

Christian la Fougère

P577

2011-07-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51493250

http://www.w3.org/2001/XMLSchema#string

P698

21757446

http://www.w3.org/2001/XMLSchema#string

P932

3145468

http://www.w3.org/2001/XMLSchema#string